Dr. Heba Nagi Iskandar, MD

Dr. Iskandar practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Iskandar's NPI, 1457550782, was assigned on July 17, 2007. Dr. Iskandar graduated from Washington University School of Medicine in 2007. Dr. Iskandar holds Georgia license 69828.

Dr. Iskandar's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Iskandar's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Iskandar is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Iskandar to 1 more hospital and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iskandar practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Iskandar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Iskandar is licensed in Georgia.

CMS data shows 195 Medicare services from Dr. Iskandar across 7 procedure codes in 2024, for 133 Medicare patients. Medicare paid $21,838 for them.

CMS counts 133 Medicare patients who saw Dr. Iskandar in 2024. The largest group is 65 to 74, with 61 patients. 71% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iskandar's median patient age at 58, with 62% women.

In 2024, Dr. Iskandar wrote 729 Medicare Part D claims for 195 patients. 54% of them were for generic drugs. CMS names the drug for 545 of them, across 13 drugs with 11 or more claims each, at $5,872,280 in total drug cost. In 2023, CMS named 777 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Iskandar for performance year 2024, reported through an alternative payment model (APM). Dr. Iskandar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iskandar as offering telehealth. CMS counts 46 procedures of colonoscopy by Dr. Iskandar, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Iskandar, published from 2012 to 2023. 2014 was the busiest year, with 2. The most frequent topics are Inflammatory Bowel Diseases, Colitis, Ulcerative and Crohn Disease. Dr. Iskandar has published most often in Inflamm Bowel Dis. Dr. Iskandar's most frequent co-authors are Tanvi Ashok Dhere, MD, Matthew Aaron Ciorba, MD and Adil Abubaker Abdalla, MD.

Dmand AI links Dr. Iskandar to 2 clinical trials. Conditions studied include Colitis, Ulcerative, Crohn Disease and Colitis.

CMS Open Payments shows 30 general payments to Dr. Iskandar from 9 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 88% of the total. Abbvie Inc. paid the most, $5,030.

Dr. Iskandar graduated from Washington University School of Medicine in 2007.